Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study.
Giofrè C, Fabbrocini G, Potenza C, Tiberio R, Gisondi P, Marasca C, Nuzzo CMA, Benincasa E, Bianchi L; DARWIN study group. Giofrè C, et al. Among authors: fabbrocini g. Adv Ther. 2023 Jul;40(7):3021-3037. doi: 10.1007/s12325-023-02516-y. Epub 2023 May 12. Adv Ther. 2023. PMID: 37171752 Free PMC article. Clinical Trial.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness.
Mannino M, Piccerillo A, Fabbrocini G, Quaglino P, Argenziano G, Dika E, Ascierto PA, Pellacani G, Longo C, Fargnoli MC, Bianchi L, Calzavara-Pinton P, Zalaudek I, Fava P, Scalvenzi M, Bocchino E, Di Stefani A, Peris K; and Collaborators. Mannino M, et al. Among authors: fabbrocini g. Dermatology. 2023;239(6):868-876. doi: 10.1159/000531280. Epub 2023 Jun 13. Dermatology. 2023. PMID: 37311439 Free article.
Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus.
Prignano F, Atzori L, Bellinato F, Damiani G, Galeone C, Mariani P, Potenza C, Scopinaro A, Piaserico S, Fabbrocini G; Italian Delphi GPP Group. Prignano F, et al. Among authors: fabbrocini g. Dermatology. 2024;240(3):414-424. doi: 10.1159/000538072. Epub 2024 Mar 18. Dermatology. 2024. PMID: 38493762 Free PMC article.
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel.
Offidani A, Marzano AV, Peris K, Molinelli E, Bettoli V, Magnoni C, Vaienti L, Pappagallo G, Amerio P, Atzori L, Balato A, Bianchi L, Bongiorno MR, Contedini F, Dapavo P, Di Benedetto G, Dini V, Donini M, Fabbrocini G, Fania L, Foti C, Gatti A, Guarneri C, Malara G, Manfredini M, Morrone P, Naldi L, Parodi A, Potenza C, Schianchi S, Stingeni L, Trovato E, Vaira F, Valenti M, Venturini M, Chiricozzi A, Prignano F. Offidani A, et al. Among authors: fabbrocini g. Dermatology. 2024;240(5-6):885-896. doi: 10.1159/000539264. Epub 2024 Jul 18. Dermatology. 2024. PMID: 39004081 Free PMC article.
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
Fargnoli MC, Antonetti P, Atzori L, Taddeucci P, Di Stefani A, Grandi V, Lospalluti L, Lacarrubba F, Vaccari S, Amerio P, Fabbrocini G, Rossi M, Campione E, Caposiena Caro RD, Moscarella E, Rongioletti F, Pellegrini C, Peris K, Discab. Fargnoli MC, et al. Among authors: fabbrocini g. Dermatology. 2023;239(3):387-392. doi: 10.1159/000529368. Epub 2023 Feb 8. Dermatology. 2023. PMID: 36754039
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire.
Camela E, Villani A, Ocampo Garza SS, Costa C, Fabbrocini G, Megna M, Potestio L, Ruggiero A, Scalvenzi M. Camela E, et al. Among authors: fabbrocini g. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023177. doi: 10.5826/dpc.1303a177. Dermatol Pract Concept. 2023. PMID: 37557166 Free PMC article.
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.
Bonifati C, Lembo S, Richetta AG, Romanelli M, Satolli F, Corazza M, Atzori L, Lasagni C, Potenza C, Savoia P, Bardazzi F, Di Lernia VG, Bianchi L, Fabbrocini G, Giofrè C, Zichichi L, Guarneri C, Pallotta S, Fargnoli MC, Loconsole F, Offidani A, Burlando M, Piaserico S, Peris K, Papini M, Carrera CG, Costanzo A, Prignano F, Bongiorno R, Dapavo P, Stingeni L, Donini M, Micali G, Rongioletti F, Stinco G, Gramiccia T, Cantini G, Argenziano G. Bonifati C, et al. Among authors: fabbrocini g. J Eur Acad Dermatol Venereol. 2024 Jun 26. doi: 10.1111/jdv.20187. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38924150
Management and treatment of non-classic human scabies.
Picone V, Martora F, DE Fata Salvatores G, Spennato S, Gallo L, Fabbrocini G. Picone V, et al. Among authors: fabbrocini g. Ital J Dermatol Venerol. 2024 Apr;159(2):196-197. doi: 10.23736/S2784-8671.24.07550-9. Epub 2024 Feb 2. Ital J Dermatol Venerol. 2024. PMID: 38305081 No abstract available.
Severe symptomatic late onset dermographism after mRNA COVID-19 vaccine.
Patruno C, Fabbrocini G, Napolitano M. Patruno C, et al. Among authors: fabbrocini g. Ital J Dermatol Venerol. 2024 Feb;159(1):60-61. doi: 10.23736/S2784-8671.23.07454-6. Epub 2024 Jan 23. Ital J Dermatol Venerol. 2024. PMID: 38261308 No abstract available.
773 results